For the Inventor, By the Inventor

Enter assignee name

San Clemente, CA, United States of America

Reshape Lifesciences Inc.

USPTO Granted Patents = 19

EPO Patents = 5

Trademarks = 22

Forward Citations = 18

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Neil R Drake (10 out of 41 patents)

Mark C Brister (10 out of 191 patents)

Antonio C Llevares (8 out of 39 patents)

4. Andrew P Rasdal (8 out of 37 patents)

5. Dubravka Markovic (7 out of 47 patents)

6. Amy D L VandenBerg (7 out of 30 patents)

7. Matthew S Lake (4 out of 15 patents)

8. Josefina Nider (4 out of 15 patents)

9. Raj Nihalani (4 out of 10 patents)

10. Jonathan J Waataja (4 out of 6 patents)

11. Paul D Faucher (4 out of 28 patents)

12. Nelson Quintana (3 out of 32 patents)

13. Mark B Knudson (3 out of 127 patents)

14. Daniel J Proctor (3 out of 7 patents)

15. Katherine S Tweden (3 out of 57 patents)

19 patents: Sort by Forward Citations

1. 12440358 - Pressure control system for intragastric device (2025-10-14),

2. 12350179 - Intragastric device (2025-07-08),

3. 12329972 - High-frequency low duty cycle patterns for nerual regulation (2025-06-17),

4. 12311174 - Simultaneous multi-site vagus nerve neuromodulation for improved glycemic control system and methods (2025-05-27),

5. 12102547 - Intragastric volume-occupying device and method for fabricating same (2024-10-01),

6. 12090075 - Intragastric device (2024-09-17),

7. 11974934 - Intragastric device (2024-05-07),

8. 11819433 - Pressure control system for intragastric device (2023-11-21),

9. 11779482 - Intragastric device (2023-10-10),

10. 11737899 - Intragastric device (2023-08-29),

11. 11730619 - Systems and methods for determining failure of intragastric devices (2023-08-22),

12. 11534610 - High-frequency low duty cycle patterns for neural regulation (2022-12-27),

13. 11219543 - Intragastric device (2022-01-11),

14. 11033415 - Gastric restriction devices for treating obesity (2021-06-15),

15. 10722714 - Methods and systems for glucose regulation (2020-07-28),

Reshape Lifesciences is a medical technology company focused on developing and commercializing innovative technologies in the field of obesity interventions. Their FDA-approved products include the ReShape Balloon, an intragastric dual balloon system for weight loss, and the ReShape Vest, a non-surgical device for endoscopic gastric restriction. With a commitment to improving patient outcomes, Reshape Lifesciences is revolutionizing the approach to weight loss and metabolic diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

19 Patents

#16 in San Clemente, CA

#3,975 in California

#16,627 in US

#31,712 in the World

San Clemente, CA, United States of America

Reshape Lifesciences Inc.

Forward Citations = 18

25 inventors:

Neil R Drake (10 out of 41 patents)

Mark C Brister (10 out of 191 patents)

Antonio C Llevares (8 out of 39 patents)

4. Andrew P Rasdal (8 out of 37 patents)

5. Dubravka Markovic (7 out of 47 patents)

Please report any incorrect information to support@idiyas.com

Loading…